 |
|
New genes present drug targets for managing cholesterol and glucose levels
December 08, 2008ANN ARBOR, Mich.---Scientists have identified 12 new genes that are somewhat strange bedfellows: Some link gallstones and blood cholesterol levels, others link melatonin and sleep patterns to small increases in glucose levels and larger jumps in the risk of diabetes.
While these associations are surprising, all the genes are potential new drug targets and some of them could help explain conditions that have been a mystery. Nature Genetics will publish two papers explaining the findings online Dec 7, in advance of the January print edition.
The 12 new genes relate to cholesterol and glucose levels, but several point to somewhat surprising links between these traits and other conditions, said Goncalo Abecasis, associate professor of biostatistics at the University of Michigan School of Public Health who co-directed the cholesterol study. Cristen Willer, a postdoctoral researcher working with Michael Boehnke, a professor at the U-M SPH, was lead analyst and joint first author of the study along with Sekar Kathiresan of Massachusetts General Hospital and Harvard Medical School.
Cholesterol is a strong predictor of heart disease and in a previous study, Abecasis, Boehnke, Willer and colleagues had shown that genetic variants that raise LDL cholesterol (low density lipoprotein or so-called bad cholesterol) levels also increase the risk of heart disease. The current study describes the most detailed assessment of the genetics of cholesterol to date, examining genetic variants and cholesterol levels in more than 40,000 individuals.
"An important finding is that several of these genes have multiple different changes that can affect cholesterol," Willer said. For example, in the PCSK9 gene there are common variants that affect about 40 percent of the population and increase LDL by about 3-6 milligrams per deciliter, a fairly small amount. Another variant affects roughly 2 percent of individuals but increases LDL by about 15-30 milligrams per deciliter. Finally, there are extremely rare changes in the same gene that affect fewer than 1 in 1000 people but can increase LDL by well over 100 milligrams per deciliter.
"We think looking at this list of genes in individuals with extremely high cholesterol may clarify a lot of those unexplained cases," Abecasis said.
In the cholesterol study, U-M scientists and collaborators at more than 10 institutions in the U.S. and Europe located 30 genetic variants associated with cholesterol levels, including 11 new ones. Notably, several of the newly implicated genetic variants were also related to the risk of gallstones and certain rare forms of diabetes.
"Each of these genes is a potentially interesting drug target," said Abecasis. Statins, a class of cholesterol lowering drugs used to reduce the risk of heart disease, target the HMGCR gene, one of the genes identified in the study. The other genes identified in the study could lead to entirely new and more effective therapies to manage cholesterol levels and reduce the risk of heart disease. In addition, the genetic changes they identify can also help predict whether each individual will develop high LDL or low HDL.
In the paper studying glucose levels, Abecasis and Boehnke collaborated with researchers across the globe to discover genetic changes strongly associated with a small increase in glucose levels in non-diabetic individuals. They also found the same changes increased the risk of developing diabetes by up to 20 percent.
"Observing an increased risk for diabetes was surprising because the changes in glucose levels were well within the normal range," said Boehnke, who has studied the genetics of diabetes for more than 15 years.
The gene, called the melatonin receptor, helps regulate the circadian clock, among other things. The finding strengthens the association between disrupted sleep patterns and diabetes, Boehnke said.
In the glucose study, scientists looked at the genomes of 36,000 individuals.
University of Michigan
Cholesterol is a strong predictor of heart disease and in a previous study, Abecasis, Boehnke, Willer and colleagues had shown that genetic variants that raise LDL cholesterol (low density lipoprotein or so-called bad cholesterol) levels also increase the risk of heart disease. The current study describes the most detailed assessment of the genetics of cholesterol to date, examining genetic variants and cholesterol levels in more than 40,000 individuals.
"An important finding is that several of these genes have multiple different changes that can affect cholesterol," Willer said. For example, in the PCSK9 gene there are common variants that affect about 40 percent of the population and increase LDL by about 3-6 milligrams per deciliter, a fairly small amount. Another variant affects roughly 2 percent of individuals but increases LDL by about 15-30 milligrams per deciliter. Finally, there are extremely rare changes in the same gene that affect fewer than 1 in 1000 people but can increase LDL by well over 100 milligrams per deciliter.
"We think looking at this list of genes in individuals with extremely high cholesterol may clarify a lot of those unexplained cases," Abecasis said.
In the cholesterol study, U-M scientists and collaborators at more than 10 institutions in the U.S. and Europe located 30 genetic variants associated with cholesterol levels, including 11 new ones. Notably, several of the newly implicated genetic variants were also related to the risk of gallstones and certain rare forms of diabetes.
"Each of these genes is a potentially interesting drug target," said Abecasis. Statins, a class of cholesterol lowering drugs used to reduce the risk of heart disease, target the HMGCR gene, one of the genes identified in the study. The other genes identified in the study could lead to entirely new and more effective therapies to manage cholesterol levels and reduce the risk of heart disease. In addition, the genetic changes they identify can also help predict whether each individual will develop high LDL or low HDL.
In the paper studying glucose levels, Abecasis and Boehnke collaborated with researchers across the globe to discover genetic changes strongly associated with a small increase in glucose levels in non-diabetic individuals. They also found the same changes increased the risk of developing diabetes by up to 20 percent.
"Observing an increased risk for diabetes was surprising because the changes in glucose levels were well within the normal range," said Boehnke, who has studied the genetics of diabetes for more than 15 years.
The gene, called the melatonin receptor, helps regulate the circadian clock, among other things. The finding strengthens the association between disrupted sleep patterns and diabetes, Boehnke said.
In the glucose study, scientists looked at the genomes of 36,000 individuals.
University of Michigan
Glucose Levels Current Events and Glucose Levels News RSSResearchers discover mechanism of insulin production that can lead to better treatment for diabetes
How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities.
A decade later, lifestyle changes or metformin still lower type 2 diabetes risk
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.
Should children undergo surgery without a long period of fasting after feeding?
Blood glucose levels in a lot of patients fed normal liquid food (NLF) and a high calorie diet (HCD) were high.
URI nutritionist finds chewing gum can reduce calorie intake, increase energy expenditure
A nutrition professor at the University of Rhode Island studying the effects of chewing sugar-free gum on weight management has found that it can help to reduce calorie intake and increase energy expenditure.
Healthy neighborhoods may be associated with lower diabetes risk
Individuals living in neighborhoods conducive to physical activity and providing access to healthy foods may have a lower risk of developing type 2 diabetes in a five-year period, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Self monitoring of blood glucose levels helps patients with diabetes
Self-monitoring of blood glucose (SMBG) enables those with diabetes to modify their behavior, adjust their medicine and understand their disease to better manage it.
Is inhaled insulin delivery still a possibility? Why has it been a commercial failure?
The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market.
Postmenopausal women benefit from endurance training as much as younger women
Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples.
Team reveals molecular mechanism underlying a form of diabetes
By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion.
Biotransformed blueberry juice fights fat and diabetes
Juice extracted from North American lowbush blueberries, biotransformed with bacteria from the skin of the fruit, holds great promise as an anti-obesity and anti-diabetic agent.
More Glucose Levels Current Events and Glucose Levels News Articles
 |
The New Glucose Revolution What Makes My Blood Glucose Go Up . . . and Down?: 101 Frequently Asked Questions About Your Blood Glucose Levels by Dr. Dr. Jennie Brand-Miller M.D. M.D. (Author), Kaye Foster-Powell M. Nutr & Diet (Author), David Mendosa (Author), Kaye Foster-Powell B.SC. M. Nutri. & Diet (Author) Dr. Jennie Brand-Miller and Kaye Foster-Powell — authors of the New York Times best-seller The New Glucose Revolution,— and David Mendosa, a leading diabetes journalist, answer the most frequently asked questions about blood glucose levels. They address a wide range of concerns, correct common misconceptions, and educate how best to monitor and control glucose levels. Among the questions addressed are: • What is a normal blood glucose level? • What can I do to bring down my blood glucose levels when they’re high? • Can being stressed really have something to do with my high blood glucose? • Which carbohydrates will raise my blood glucose the least? • What is the glycemic index? • When I crave something sweet, what should I have? This book is for... |
 |
NuNaturals Level Right, For Blood Sugar Management, 90 Capsules by Nunaturals Dietary Supplement NuNaturals LevelRight provides herbs and nutrients th |
 |
iPet - Glucose Test Strips (25 count) by UltiMed, Inc. iPet Test Strips are used with the iPet Glucose Monitoring Kit. Container with 25 test strips. Includes 2 Glucode Chips, Code Numbers, and Instructions. 20-600 mg/dL (1.1-33.3 mmol/L) range. For testing blood sugar in capillary whole blood. Calibrated for cats and dogs. Not intended for human use. Blood Glucose home-testing for orientation purposes. Home-testing does not substitute for veterinary advice. |
 |
Taking Care - Diabetic Glucose Level Testing Diabetes Prevention Society (Primary Contributor) |
|
A1C Why High Levels are Bad For You. Relation to Blood Glucose and What to do when high. Diabetes Self Help Series. DVD DN3.101DIAE Starring: Dr. Anup. MD Directed By: R Joshi A1C Levels are useful in both the diagnosis and for the follow up of a diabetic. A1C is like the crystal ball that shows you your future. How is that? High levels of A1C in a known diabetic correlate with higher chances of blindness, kidney failure, heart attack, hospital admission and diabetes related expenses. This is truly a reflection of what of what the future holds for the patient. The best part is that with proper actions and a to-do list the A1C levels can be brought down to 'Normal' within about a six month period. This DVD is a full 75 minute presentation (part of series of our over Diabetes Education Series' and discusses in very simple language how A1C is formed in the body, what are the normal and the abnormal values, what is the significance of abnormal values and how to fix... | |
 |
Glucozene-Rx-Hi-Tech Glucose Transporter/Insulin Mimicker, 555mg 30caps by Hi-Tech GLUCOZENE-RX Blood Sugar Supplement is a state-of-the-art herbal alternative that regulates glucose and sugar levels. |
 |
What Makes My Blood Glucose Go Up...And Down? And 101 Other Frequently Asked Questions About Your Blood Glucose Levels by Jennie Brand-Miller (Author), Kaye Foster-Powell (Author), Rick Mendosa (Author) Finally, all in one place, here are answers to the questions millions of people have about the fluctuations in their blood glucose—or blood sugar—levels In this accessible, informative new book, Dr. Jennie Brand-Miller and Kaye Foster-Powell—authors of the New York Times bestseller The New Glucose Revolution, the authoritative guide to the glycemic index—along with leading diabetes journalist Rick Mendosa, answer the most frequently asked questions about your blood glucose levels. They address a wide range of concerns, correct common misconceptions, and set out to educate how best to monitor and control glucose levels to maintain optimum health. Among the questions they address are: • What is a normal blood glucose level? • What can I do to bring down my... |
 |
The Sugar Destoyer by LifeSpa by John Douilard Sugar Destroyer is a formula that has been used for thousands of years for hypoglycemic and diabetic conditions. To influence hypoglycemia, Sugar Destroyer dulls the ability of the taste buds to recognize sweets, so naturally, the craving for sweets diminishes. Sugar Destroyer also helps stabilize the production of insulin, thereby contributing to energy stabilization. One study showed this herb actually restimulated the beta cells in the pancreas to begin producing insulin in insulin-dependent diabetics. Clinically, I see wonderful results with this product in lowering insulin replacement needs. I also see excellent results for hypoglycemics who are hypersensitive to sugar. Once these patients stabilize their conditions with Sugar Destroyer, they are able to tolerate sugar again in... |
 |
>Accuchek aviva 2 lvl cntrl sol. ACCU-CHEK Aviva 2 Level Glucose Control Solution by DiabeticDiabetic misc # Contents: Level 1 2.5 mL, Level 2 2.5 mL # For control testing with the ACCU-CHEK Aviva system # For in vitro diagnostic use |
 |
The G-Index Diet: Control Your Glucose Level and Lose Weight Now by Richard Podell (Author), William Proctor (Author) A specially designed diet guide uses scientific methods to determine which diet foods actually show results and how others can trigger out-of-control eating instead of burning fat. Reprint. |
| © 2009 BrightSurf.com |